Chronic  	Chronic  	 JJ	B-NP
migraine 	migraine 	 NN	I-NP
:  	:  	 :	O
treatment  	treatment  	 NN	O
We  	We  	 PRP	O
define  	define  	 VB	O
chronic  	chronic  	 JJ	B-NP
migraine  	migraine  	 NN	I-NP
as  	as  	 IN	O
that  	that  	 DT	O
clinical  	clinical  	 JJ	B-NP
situation  	situation  	 NN	I-NP
in  	in  	 IN	O
which  	which  	 WDT	O
migraine  	migraine  	 VBP	B-NP
attacks  	attacks  	 NNS	I-NP
appear  	appear  	 VBP	O
15  	15  	 CD	O
or  	or  	 CC	O
more  	more  	 JJR	O
days  	days  	 NNS	O
per  	per  	 IN	O
month 	month 	 NN	O
.  	.  	 .	O
Until  	Until  	 IN	O
recently 	recently 	 RB	O
,  	,  	 ,	O
and  	and  	 CC	O
in  	in  	 IN	O
spite  	spite  	 NN	O
of  	of  	 IN	O
its  	its  	 PRP$	O
negative  	negative  	 JJ	B-NP
impact 	impact 	 NN	I-NP
,  	,  	 ,	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
chronic  	chronic  	 JJ	B-NP
migraine  	migraine  	 NN	I-NP
were  	were  	 VBD	O
excluded  	excluded  	 VBN	O
of  	of  	 IN	O
the  	the  	 DT	O
clinical  	clinical  	 JJ	B-NP
trials 	trials 	 NNS	I-NP
.  	.  	 .	O
This  	This  	 DT	O
manuscript  	manuscript  	 NN	O
revises  	revises  	 VBD	O
the  	the  	 DT	O
current  	current  	 JJ	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
chronic  	chronic  	 JJ	B-NP
migraine 	migraine 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
first  	first  	 JJ	O
step  	step  	 NN	O
should  	should  	 MD	O
include  	include  	 VB	O
the  	the  	 DT	O
avoidance  	avoidance  	 NN	O
of  	of  	 IN	O
potential  	potential  	 JJ	B-NP
precipitating 	precipitating 	 NNS	I-NP
/ 	/ 	 VBP	I-NP
aggravating  	aggravating  	 VBG	I-NP
factors  	factors  	 NNS	I-NP
for  	for  	 IN	I-NP
chronic  	chronic  	 JJ	I-NP
migraine 	migraine 	 NN	I-NP
,  	,  	 ,	O
mainly  	mainly  	 RB	O
analgesic  	analgesic  	 JJ	B-NP
overuse  	overuse  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
comorbid  	comorbid  	 JJ	B-NP
disorders 	disorders 	 NNS	I-NP
,  	,  	 ,	O
such  	such  	 JJ	O
as  	as  	 IN	O
anxiety  	anxiety  	 NN	B-NP
and  	and  	 CC	O
depression 	depression 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
symptomatic  	symptomatic  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
should  	should  	 MD	O
be  	be  	 VB	O
based  	based  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
nonsteroidal  	nonsteroidal  	 JJ	B-NP
anti-inflammatory  	anti-inflammatory  	 JJ	I-NP
agents  	agents  	 NNS	I-NP
and  	and  	 CC	O
triptans  	triptans  	 NNS	B-NP
( 	( 	 -LRB-	O
in  	in  	 IN	O
this  	this  	 DT	O
case  	case  	 NN	O
< 	< 	 SYM	O
10  	10  	 CD	O
days  	days  	 NNS	O
per  	per  	 IN	O
month 	month 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
It  	It  	 PRP	O
is  	is  	 VBZ	O
necessary  	necessary  	 JJ	O
to  	to  	 TO	O
avoid  	avoid  	 VB	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
combined  	combined  	 JJ	O
analgesics 	analgesics 	 NN	O
,  	,  	 ,	O
opioids  	opioids  	 NN	B-NP
and  	and  	 CC	O
ergotamine-containing  	ergotamine-containing  	 JJ	B-NP
medications 	medications 	 NN	I-NP
.  	.  	 .	O
Preventive  	Preventive  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
includes  	includes  	 VBZ	O
a  	a  	 DT	O
' 	' 	 POS	O
transitional 	transitional 	 NN	O
'  	'  	 POS	O
treatment  	treatment  	 NN	O
with  	with  	 IN	O
nonsteroidal  	nonsteroidal  	 JJ	B-NP
anti-inflammatory  	anti-inflammatory  	 JJ	I-NP
agents  	agents  	 NNS	I-NP
or  	or  	 CC	O
steroids 	steroids 	 NNS	O
,  	,  	 ,	O
while  	while  	 IN	O
preventive  	preventive  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
exerts  	exerts  	 VBD	O
its  	its  	 PRP$	O
actions 	actions 	 NNS	O
.  	.  	 .	O
Even  	Even  	 RB	O
though  	though  	 IN	O
those  	those  	 DT	O
medications  	medications  	 JJ	O
efficacious  	efficacious  	 NN	O
in  	in  	 IN	O
episodic  	episodic  	 JJ	B-NP
migraine  	migraine  	 JJ	I-NP
prevention  	prevention  	 NNS	I-NP
are  	are  	 VBP	O
used 	used 	 VBN	O
,  	,  	 ,	O
the  	the  	 DT	O
only  	only  	 JJ	O
drugs  	drugs  	 NNS	O
with  	with  	 IN	O
demonstrated  	demonstrated  	 JJ	O
efficacy  	efficacy  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
preventive  	preventive  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
of  	of  	 IN	I-NP
chronic  	chronic  	 JJ	I-NP
migraine  	migraine  	 NNS	I-NP
are  	are  	 VBP	O
topiramate  	topiramate  	 VBN	O
and  	and  	 CC	O
pericranial  	pericranial  	 JJ	B-NP
infiltrations  	infiltrations  	 NN	I-NP
of  	of  	 IN	I-NP
Onabotulinumtoxin  	Onabotulinumtoxin  	 NNP	I-NP
A 	A 	 NNP	O
.  	.  	 .	O
